KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) EPS (Basic) (2016 - 2025)

Biolife Solutions (BLFS) has disclosed EPS (Basic) for 16 consecutive years, with $0.08 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Basic) fell 84.62% to $0.08 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.25, a 34.21% increase, with the full-year FY2025 number at -$0.25, down 31.58% from a year prior.
  • EPS (Basic) was $0.08 for Q4 2025 at Biolife Solutions, up from $0.01 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.94 in Q4 2023 to a low of -$1.71 in Q2 2022.
  • A 5-year average of -$0.22 and a median of -$0.22 in 2024 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): crashed 955.0% in 2022, then surged 179.66% in 2023.
  • Biolife Solutions' EPS (Basic) stood at -$0.41 in 2021, then plummeted by 187.8% to -$1.18 in 2022, then skyrocketed by 179.66% to $0.94 in 2023, then plummeted by 44.68% to $0.52 in 2024, then plummeted by 84.62% to $0.08 in 2025.
  • Per Business Quant, the three most recent readings for BLFS's EPS (Basic) are $0.08 (Q4 2025), $0.01 (Q3 2025), and -$0.33 (Q2 2025).